{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T06:51:23Z","timestamp":1791355883188,"version":"4.3.1"},"reference-count":52,"publisher":"American Society of Hematology","issue":"3","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2016,7,21]]},"abstract":"<jats:title>Key Points<\/jats:title>\n               <jats:p>First prospective, controlled study to identify complex karyotypes as an independent prognostic factor of survival in CLL. First study to show that mutations in KRAS or POT1 impact treatment response and survival after chemoimmunotherapy.<\/jats:p>","DOI":"10.1182\/blood-2016-01-691550","type":"journal-article","created":{"date-parts":[[2016,5,26]],"date-time":"2016-05-26T04:24:19Z","timestamp":1464236659000},"page":"395-404","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":113,"title":["Complex karyotypes and KRAS and POT1 mutations impact outcome in CLL after chlorambucil-based chemotherapy or chemoimmunotherapy"],"prefix":"10.1182","volume":"128","author":[{"given":"Carmen Diana","family":"Herling","sequence":"first","affiliation":[{"name":"Department of Internal Medicine I, Center of Integrated Oncology Cologne-Bonn,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Klaum\u00fcnzer","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, Center of Integrated Oncology Cologne-Bonn,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristiano Krings","family":"Rocha","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, Center of Integrated Oncology Cologne-Bonn,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janine","family":"Altm\u00fcller","sequence":"additional","affiliation":[{"name":"Cologne Center for Genomics, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holger","family":"Thiele","sequence":"additional","affiliation":[{"name":"Cologne Center for Genomics, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmin","family":"Bahlo","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, Center of Integrated Oncology Cologne-Bonn,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Kluth","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, Center of Integrated Oncology Cologne-Bonn,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuliano","family":"Crispatzu","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, Center of Integrated Oncology Cologne-Bonn,"},{"name":"Cologne Excellence Cluster on Cellular Stress Response in Aging-Associated Diseases, University of Cologne, Cologne, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Herling","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, Center of Integrated Oncology Cologne-Bonn,"},{"name":"Cologne Excellence Cluster on Cellular Stress Response in Aging-Associated Diseases, University of Cologne, Cologne, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Schiller","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, Center of Integrated Oncology Cologne-Bonn,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Engelke","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, Center of Integrated Oncology Cologne-Bonn,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugen","family":"Tausch","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine III, University Hospital Ulm, Ulm, Germany; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hartmut","family":"D\u00f6hner","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine III, University Hospital Ulm, Ulm, Germany; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten","family":"Fischer","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, Center of Integrated Oncology Cologne-Bonn,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentin","family":"Goede","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, Center of Integrated Oncology Cologne-Bonn,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"N\u00fcrnberg","sequence":"additional","affiliation":[{"name":"Cologne Center for Genomics, and"},{"name":"Cologne Excellence Cluster on Cellular Stress Response in Aging-Associated Diseases, University of Cologne, Cologne, Germany;"},{"name":"Center for Molecular Medicine Cologne, University of Cologne, Cologne, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans Christian","family":"Reinhardt","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, Center of Integrated Oncology Cologne-Bonn,"},{"name":"Cologne Excellence Cluster on Cellular Stress Response in Aging-Associated Diseases, University of Cologne, Cologne, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Stilgenbauer","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine III, University Hospital Ulm, Ulm, Germany; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Hallek","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, Center of Integrated Oncology Cologne-Bonn,"},{"name":"Cologne Excellence Cluster on Cellular Stress Response in Aging-Associated Diseases, University of Cologne, Cologne, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl-Anton","family":"Kreuzer","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, Center of Integrated Oncology Cologne-Bonn,"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"26","key":"2019111902572443200_B1","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1056\/NEJM200012283432602","article-title":"Genomic aberrations and survival in chronic lymphocytic leukemia.","volume":"343","author":"D\u00f6hner","year":"2000","journal-title":"N Engl J Med"},{"issue":"7574","key":"2019111902572443200_B2","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/nature15395","article-title":"Mutations driving CLL and their evolution in progression and relapse.","volume":"526","author":"Landau","year":"2015","journal-title":"Nature"},{"issue":"7354","key":"2019111902572443200_B3","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nature10113","article-title":"Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia.","volume":"475","author":"Puente","year":"2011","journal-title":"Nature"},{"issue":"1","key":"2019111902572443200_B4","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/ng.1032","article-title":"Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia.","volume":"44","author":"Quesada","year":"2011","journal-title":"Nat Genet"},{"issue":"26","key":"2019111902572443200_B5","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1056\/NEJMoa1109016","article-title":"SF3B1 and other novel cancer genes in chronic lymphocytic leukemia.","volume":"365","author":"Wang","year":"2011","journal-title":"N Engl J Med"},{"issue":"9","key":"2019111902572443200_B6","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1158\/2159-8290.CD-14-0104","article-title":"Acquired initiating mutations in early hematopoietic cells of CLL patients.","volume":"4","author":"Damm","year":"2014","journal-title":"Cancer Discov"},{"issue":"2","key":"2019111902572443200_B7","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/leu.2014.196","article-title":"Recurrent mutations refine prognosis in chronic lymphocytic leukemia.","volume":"29","author":"Baliakas","year":"2015","journal-title":"Leukemia"},{"issue":"3","key":"2019111902572443200_B8","doi-asserted-by":"crossref","first-page":"437","DOI":"10.3324\/haematol.2011.060129","article-title":"NOTCH1 mutations in +12 chronic lymphocytic leukemia (CLL) confer an unfavorable prognosis, induce a distinctive transcriptional profiling and refine the intermediate prognosis of +12 CLL.","volume":"97","author":"Del Giudice","year":"2012","journal-title":"Haematologica"},{"issue":"7","key":"2019111902572443200_B9","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1084\/jem.20110921","article-title":"Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation.","volume":"208","author":"Fabbri","year":"2011","journal-title":"J Exp Med"},{"issue":"1","key":"2019111902572443200_B10","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/leu.2013.263","article-title":"SF3B1 mutations correlated to cytogenetics and mutations in NOTCH1, FBXW7, MYD88, XPO1 and TP53 in 1160 untreated CLL patients.","volume":"28","author":"Jeromin","year":"2014","journal-title":"Leukemia"},{"issue":"26","key":"2019111902572443200_B11","doi-asserted-by":"crossref","first-page":"6904","DOI":"10.1182\/blood-2011-08-373159","article-title":"Mutations of the SF3B1 splicing factor in chronic lymphocytic leukemia: association with progression and fludarabine-refractoriness.","volume":"118","author":"Rossi","year":"2011","journal-title":"Blood"},{"issue":"2","key":"2019111902572443200_B12","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1182\/blood-2011-09-379966","article-title":"Mutations of NOTCH1 are an independent predictor of survival in chronic lymphocytic leukemia.","volume":"119","author":"Rossi","year":"2012","journal-title":"Blood"},{"issue":"5","key":"2019111902572443200_B13","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1038\/leu.2012.357","article-title":"NOTCH1 mutations identify a genetic subgroup of chronic lymphocytic leukemia patients with high risk of transformation and poor outcome.","volume":"27","author":"Villamor","year":"2013","journal-title":"Leukemia"},{"issue":"2","key":"2019111902572443200_B14","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1182\/blood-2005-05-2093","article-title":"Chromosomal translocations are associated with poor prognosis in chronic lymphocytic leukemia.","volume":"107","author":"Mayr","year":"2006","journal-title":"Blood"},{"issue":"11","key":"2019111902572443200_B15","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1056\/NEJM199009133231105","article-title":"Prognostic subgroups in B-cell chronic lymphocytic leukemia defined by specific chromosomal abnormalities.","volume":"323","author":"Juliusson","year":"1990","journal-title":"N Engl J Med"},{"issue":"12","key":"2019111902572443200_B16","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1038\/sj.leu.2404935","article-title":"Comprehensive genetic characterization of CLL: a study on 506 cases analysed with chromosome banding analysis, interphase FISH, IgV(H) status and immunophenotyping.","volume":"21","author":"Haferlach","year":"2007","journal-title":"Leukemia"},{"issue":"8","key":"2019111902572443200_B17","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1038\/sj.leu.2404764","article-title":"Chromosomal translocations independently predict treatment failure, treatment-free survival and overall survival in B-cell chronic lymphocytic leukemia patients treated with cladribine.","volume":"21","author":"Van Den Neste","year":"2007","journal-title":"Leukemia"},{"issue":"20","key":"2019111902572443200_B18","doi-asserted-by":"crossref","first-page":"3612","DOI":"10.1002\/cncr.29566","article-title":"Complex karyotype is a stronger predictor than del(17p) for an inferior outcome in relapsed or refractory chronic lymphocytic leukemia patients treated with ibrutinib-based regimens.","volume":"121","author":"Thompson","year":"2015","journal-title":"Cancer"},{"issue":"4","key":"2019111902572443200_B19","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1046\/j.1365-2141.2002.03719.x","article-title":"CD40L stimulation enhances the ability of conventional metaphase cytogenetics to detect chromosome aberrations in B-cell chronic lymphocytic leukaemia cells.","volume":"118","author":"Buhmann","year":"2002","journal-title":"Br J Haematol"},{"issue":"9","key":"2019111902572443200_B20","doi-asserted-by":"crossref","first-page":"3152","DOI":"10.1182\/blood-2006-02-005322","article-title":"Immunostimulatory oligonucleotide-induced metaphase cytogenetics detect chromosomal aberrations in 80% of CLL patients: A study of 132 CLL cases with correlation to FISH, IgVH status, and CD38 expression.","volume":"108","author":"Dicker","year":"2006","journal-title":"Blood"},{"issue":"2","key":"2019111902572443200_B21","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.cancergen.2010.12.006","article-title":"Enhanced detection of chromosomal abnormalities in chronic lymphocytic leukemia by conventional cytogenetics using CpG oligonucleotide in combination with pokeweed mitogen and phorbol myristate acetate.","volume":"204","author":"Muthusamy","year":"2011","journal-title":"Cancer Genet"},{"issue":"3","key":"2019111902572443200_B22","doi-asserted-by":"crossref","first-page":"163","DOI":"10.2165\/11587650-000000000-00000","article-title":"Optimal pharmacotherapeutic management of chronic lymphocytic leukaemia: considerations in the elderly.","volume":"28","author":"Goede","year":"2011","journal-title":"Drugs Aging"},{"issue":"12","key":"2019111902572443200_B23","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1056\/NEJMoa1313984","article-title":"Obinutuzumab plus chlorambucil in patients with CLL and coexisting conditions.","volume":"370","author":"Goede","year":"2014","journal-title":"N Engl J Med"},{"issue":"7","key":"2019111902572443200_B24","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1038\/leu.2015.14","article-title":"Obinutuzumab as frontline treatment of chronic lymphocytic leukemia: updated results of the CLL11 study.","volume":"29","author":"Goede","year":"2015","journal-title":"Leukemia"},{"issue":"21","key":"2019111902572443200_B25","doi-asserted-by":"crossref","first-page":"3247","DOI":"10.1182\/blood-2014-01-546150","article-title":"Gene mutations and treatment outcome in chronic lymphocytic leukemia: results from the CLL8 trial.","volume":"123","author":"Stilgenbauer","year":"2014","journal-title":"Blood"},{"issue":"14","key":"2019111902572443200_B26","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","article-title":"Fast and accurate short read alignment with Burrows-Wheeler transform.","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics"},{"issue":"9","key":"2019111902572443200_B27","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1101\/gr.107524.110","article-title":"The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data.","volume":"20","author":"McKenna","year":"2010","journal-title":"Genome Res"},{"issue":"1","key":"2019111902572443200_B28","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1093\/nar\/29.1.308","article-title":"dbSNP: the NCBI database of genetic variation.","volume":"29","author":"Sherry","year":"2001","journal-title":"Nucleic Acids Res"},{"issue":"7422","key":"2019111902572443200_B29","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/nature11632","article-title":"An integrated map of genetic variation from 1,092 human genomes.","volume":"491","author":"Abecasis","year":"2012","journal-title":"Nature"},{"key":"2019111902572443200_B30"},{"key":"2019111902572443200_B31","article-title":"Analysis of protein-coding genetic variation in 60,706 humans.","author":"Lek","journal-title":"bioRxiv"},{"issue":"Database issue","key":"2019111902572443200_B32","doi-asserted-by":"crossref","first-page":"D805","DOI":"10.1093\/nar\/gku1075","article-title":"COSMIC: exploring the world\u2019s knowledge of somatic mutations in human cancer.","volume":"43","author":"Forbes","year":"2015","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"2019111902572443200_B33","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/j.1532-5415.1995.tb06377.x","article-title":"Validation of the Cumulative Illness Rating Scale in a geriatric residential population.","volume":"43","author":"Parmelee","year":"1995","journal-title":"J Am Geriatr Soc"},{"issue":"12","key":"2019111902572443200_B34","doi-asserted-by":"crossref","first-page":"5446","DOI":"10.1182\/blood-2007-06-093906","article-title":"Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines.","volume":"111","author":"Hallek","year":"2008","journal-title":"Blood"},{"issue":"5","key":"2019111902572443200_B35","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1182\/blood-2007-07-099432","article-title":"Genomic complexity identifies patients with aggressive chronic lymphocytic leukemia.","volume":"112","author":"Kujawski","year":"2008","journal-title":"Blood"},{"issue":"2","key":"2019111902572443200_B36","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.jmoldx.2012.09.006","article-title":"Genomic variation by whole-genome SNP mapping arrays predicts time-to-event outcome in patients with chronic lymphocytic leukemia: a comparison of CLL and HapMap genotypes.","volume":"15","author":"Schweighofer","year":"2013","journal-title":"J Mol Diagn"},{"issue":"3","key":"2019111902572443200_B37","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/ajh.23618","article-title":"Chromosomal translocations and karyotype complexity in chronic lymphocytic leukemia: a systematic reappraisal of classic cytogenetic data.","volume":"89","author":"Baliakas","year":"2014","journal-title":"Am J Hematol"},{"issue":"5","key":"2019111902572443200_B38","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1002\/ajh.23668","article-title":"Chlorambucil plus rituximab with or without maintenance rituximab as first-line treatment for elderly chronic lymphocytic leukemia patients.","volume":"89","author":"Fo\u00e0","year":"2014","journal-title":"Am J Hematol"},{"issue":"9","key":"2019111902572443200_B39","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1182\/blood-2011-08-375758","article-title":"TP53 alterations in acute myeloid leukemia with complex karyotype correlate with specific copy number alterations, monosomal karyotype, and dismal outcome.","volume":"119","author":"R\u00fccker","year":"2012","journal-title":"Blood"},{"issue":"8","key":"2019111902572443200_B40","doi-asserted-by":"crossref","first-page":"3322","DOI":"10.1182\/blood-2008-04-154070","article-title":"Monoallelic TP53 inactivation is associated with poor prognosis in chronic lymphocytic leukemia: results from a detailed genetic characterization with long-term follow-up.","volume":"112","author":"Zenz","year":"2008","journal-title":"Blood"},{"issue":"11","key":"2019111902572443200_B41","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/nrc3106","article-title":"RAS oncogenes: weaving a tumorigenic web.","volume":"11","author":"Pylayeva-Gupta","year":"2011","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"2019111902572443200_B42","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/nrc2290","article-title":"FBW7 ubiquitin ligase: a tumour suppressor at the crossroads of cell division, growth and differentiation.","volume":"8","author":"Welcker","year":"2008","journal-title":"Nat Rev Cancer"},{"issue":"17","key":"2019111902572443200_B43","doi-asserted-by":"crossref","first-page":"3244","DOI":"10.1128\/MCB.01528-13","article-title":"Chromosome instability underlies hematopoietic stem cell dysfunction and lymphoid neoplasia associated with impaired Fbw7-mediated cyclin E regulation.","volume":"34","author":"Siu","year":"2014","journal-title":"Mol Cell Biol"},{"issue":"4","key":"2019111902572443200_B44","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1182\/blood-2007-05-092759","article-title":"Short telomeres are associated with genetic complexity, high-risk genomic aberrations, and short survival in chronic lymphocytic leukemia.","volume":"111","author":"Roos","year":"2008","journal-title":"Blood"},{"issue":"6","key":"2019111902572443200_B45","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1038\/leu.2008.399","article-title":"Telomere length is an independent predictor of survival, treatment requirement and Richter\u2019s syndrome transformation in chronic lymphocytic leukemia.","volume":"23","author":"Rossi","year":"2009","journal-title":"Leukemia"},{"issue":"12","key":"2019111902572443200_B46","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1038\/leu.2015.217","article-title":"Telomere length predicts progression and overall survival in chronic lymphocytic leukemia: data from the UK LRF CLL4 trial.","volume":"29","author":"Strefford","year":"2015","journal-title":"Leukemia"},{"issue":"12","key":"2019111902572443200_B47","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1038\/nsmb867","article-title":"Structure of human POT1 bound to telomeric single-stranded DNA provides a model for chromosome end-protection.","volume":"11","author":"Lei","year":"2004","journal-title":"Nat Struct Mol Biol"},{"issue":"5","key":"2019111902572443200_B48","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/ng.2584","article-title":"POT1 mutations cause telomere dysfunction in chronic lymphocytic leukemia.","volume":"45","author":"Ramsay","year":"2013","journal-title":"Nat Genet"},{"issue":"2","key":"2019111902572443200_B49","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/leu.2012.194","article-title":"Telomeres and chromosomal instability in chronic lymphocytic leukemia.","volume":"27","author":"V\u00e9ron\u00e8se","year":"2013","journal-title":"Leukemia"},{"issue":"3","key":"2019111902572443200_B50","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1042\/BJ20110314","article-title":"BRCA1-mediated repression of mutagenic end-joining of DNA double-strand breaks requires complex formation with BACH1.","volume":"441","author":"Dohrn","year":"2012","journal-title":"Biochem J"},{"issue":"1","key":"2019111902572443200_B51","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.cell.2015.05.053","article-title":"A synergistic interaction between Chk1- and MK2 inhibitors in KRAS-mutant cancer.","volume":"162","author":"Dietlein","year":"2015","journal-title":"Cell"},{"issue":"5","key":"2019111902572443200_B52","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data.","volume":"2","author":"Cerami","year":"2012","journal-title":"Cancer Discov"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/128\/3\/395\/1359337\/395.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/128\/3\/395\/1359337\/395.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,19]],"date-time":"2019-11-19T07:57:52Z","timestamp":1574150272000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/128\/3\/395\/35572\/Complex-karyotypes-and-KRAS-and-POT1-mutations"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,21]]},"references-count":52,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,7,21]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2016-01-691550","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,21]]}}}